JPWO2021198745A1 - - Google Patents

Info

Publication number
JPWO2021198745A1
JPWO2021198745A1 JP2022512485A JP2022512485A JPWO2021198745A1 JP WO2021198745 A1 JPWO2021198745 A1 JP WO2021198745A1 JP 2022512485 A JP2022512485 A JP 2022512485A JP 2022512485 A JP2022512485 A JP 2022512485A JP WO2021198745 A1 JPWO2021198745 A1 JP WO2021198745A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022512485A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2021198745A1 publication Critical patent/JPWO2021198745A1/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
JP2022512485A 2020-03-30 2020-04-07 Pending JPWO2021198745A1 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT202000006625 2020-03-30
PCT/IB2020/053313 WO2021198745A1 (ja) 2020-03-30 2020-04-07 過敏性腸症候群又は炎症性腸疾患の予防又は治療のための医薬

Publications (1)

Publication Number Publication Date
JPWO2021198745A1 true JPWO2021198745A1 (ja) 2021-10-07

Family

ID=70740699

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022512485A Pending JPWO2021198745A1 (ja) 2020-03-30 2020-04-07

Country Status (8)

Country Link
US (1) US20230149421A1 (ja)
EP (1) EP4129296A1 (ja)
JP (1) JPWO2021198745A1 (ja)
KR (1) KR20230041650A (ja)
CN (1) CN115942938A (ja)
AU (1) AU2020439775A1 (ja)
CA (1) CA3174216A1 (ja)
WO (1) WO2021198745A1 (ja)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT202100025124A1 (it) * 2021-09-30 2023-03-30 Univ Degli Studi Di Firenze Medicamento per uso nel prevenire o trattare il dolore nocicettivo e/o viscerale

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10312969A1 (de) * 2003-03-24 2004-10-07 Bayer Healthcare Ag Benzofuro-1,4-diazepin-2-on-Derivate
WO2007005233A1 (en) 2005-06-30 2007-01-11 Albemarle Corporation Brominated styrenic polymers and their preparation
KR20080023847A (ko) 2006-09-12 2008-03-17 세메스 주식회사 반도체 제조 설비의 고주파 발생 장치 및 그 방법
JP5195253B2 (ja) 2008-10-08 2013-05-08 株式会社村田製作所 電子部品の製造方法
KR101727761B1 (ko) * 2009-02-16 2017-04-17 닛뽕 케미파 가부시키가이샤 디아제핀디온 유도체
US8810562B2 (en) 2009-05-19 2014-08-19 Advanced Micro Devices, Inc. Hierarchical lossless compression
US9052439B2 (en) 2010-07-30 2015-06-09 Novartis Ag Method for making UV-absorbing ophthalmic lenses
KR101161153B1 (ko) 2010-08-20 2012-07-11 송은화 방향제가 구비된 전동식 디퓨져
KR101191251B1 (ko) 2011-12-02 2012-10-16 영남대학교 산학협력단 3단계 동적 분류를 통한 10기가급 대용량 플로우 생성 및 제어방법
KR102092147B1 (ko) * 2012-01-13 2020-03-23 닛뽕 케미파 가부시키가이샤 P2x4 수용체 길항제
JP6242614B2 (ja) 2013-07-04 2017-12-06 コンビ株式会社 乳母車
JP6257938B2 (ja) 2013-07-04 2018-01-10 コンビ株式会社 乳母車
JPWO2015005467A1 (ja) * 2013-07-12 2017-03-02 日本ケミファ株式会社 Ｐ２ｘ４受容体拮抗剤
JP6715830B2 (ja) * 2014-06-26 2020-07-01 ザ・ジョンズ・ホプキンス・ユニバーシティ 過敏性腸症候群および末梢神経系の他の病気の治療のための末梢限局性ｇａｂａポジティブアロステリックモジュレーター
WO2018104305A1 (en) * 2016-12-09 2018-06-14 Bayer Pharma Aktiengesellschaft Field of application of the invention

Also Published As

Publication number Publication date
CA3174216A1 (en) 2021-10-07
EP4129296A1 (en) 2023-02-08
CN115942938A (zh) 2023-04-07
WO2021198745A1 (ja) 2021-10-07
KR20230041650A (ko) 2023-03-24
US20230149421A1 (en) 2023-05-18
AU2020439775A1 (en) 2022-11-03

Similar Documents

Publication Publication Date Title
BR112023005462A2 (ja)
BR112023012656A2 (ja)
BR112021014123A2 (ja)
BR112022024743A2 (ja)
BR102021018859A2 (ja)
BR102021015500A2 (ja)
BR112022009896A2 (ja)
JPWO2021198745A1 (ja)
BR112023011738A2 (ja)
BR112023016292A2 (ja)
BR112023011539A2 (ja)
BR112023011610A2 (ja)
BR112023008976A2 (ja)
BR112023009656A2 (ja)
BR112023006729A2 (ja)
BR102021020147A2 (ja)
BR102021018926A2 (ja)
BR102021018167A2 (ja)
BR102021017576A2 (ja)
BR102021016837A2 (ja)
BR102021016551A2 (ja)
BR102021016375A2 (ja)
BR102021016176A2 (ja)
BR102021016200A2 (ja)
BR102021015566A2 (ja)

Legal Events

Date Code Title Description
A80 Written request to apply exceptions to lack of novelty of invention

Free format text: JAPANESE INTERMEDIATE CODE: A801

Effective date: 20221024

A80 Written request to apply exceptions to lack of novelty of invention

Free format text: JAPANESE INTERMEDIATE CODE: A80

Effective date: 20221024

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230113

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20230303

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20240402

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240625